BAXTER INTERNATIONAL INC (BAX) Risk Factors
Health CareLatest 10-K filed Feb 12, 2026Source: SEC EDGAR
WealthWire extracted and classified 38 risk factors from BAXTER INTERNATIONAL INC’s latest SEC filing, mapping each to a standardized risk taxonomy so they can be compared across every company and sector. The breakdown below shows how those disclosures distribute across risk categories.
Market & business
8 factorsFinancial
7 factorsLegal & regulatory
6 factorsOperations & people
6 factorsTechnology
5 factorsHealthcare & life sciences
2 factorsOther
2 factorsESG & reputation
2 factorsRecent key developments
Concrete developments — dated events, named agreements and instruments, legal proceedings — that BAXTER INTERNATIONAL INC surfaced in its latest filing.
- Divestiture of Kidney Care business in January 2025January 2025
- Acquisition of Hillrom in 2021, with integration taking longer than anticipated2021
- Recently decreased quarterly dividend to $0.01 per share
- Approximately $9.48 billion of indebtedness outstanding as of December 31, 2025December 31, 2025
- Repayment of $3.81 billion of legacy indebtedness in 2025 (excluding $2.00 billion repaid with new notes offering)2025
- Stated net leverage target expected by end of 2026, with possible further credit rating downgrades if not achievedend of 2026
- Hurricane Helene caused production delays and reset demand levels in IV solutions business, negatively impacting sales of certain premix products
- Possible disputes or litigation with Carlyle or Vantive under the Equity Purchase Agreement, Transition Services Agreement, or Manufacturing and Supply Agreement
- In July 2025, announced the election of Andrew Hider as President and CEOJuly 2025
- Announced other leadership transitions throughout the year
Go deeper on BAX
This page shows the category breakdown of the latest filing. The WealthWire API and dashboard add the full risk-factor text, multi-year trends, sector comparisons, and CSV export — for BAX and every other S&P 500 company.